Wood-based biochemicals are renewable, recyclable, can shorten supply chains and boost local production. And they can be used to make almost anything.

The University of Maine Forest Bioproducts Research Institute (FBRI) will upgrade its Technology Research Center (TRC) in Old Town and Process Development Center (PDC) in Jenness Hall to bolster ongoing efforts to create new bioproducts, increase production and find uses for woody biomass materials typically considered waste.

NCC and RISE Research Institutes of Sweden have commenced collaboration to test the renewable raw material lignin as a binding agent in asphalt. The project is part of the efforts to reduce emissions of greenhouse gases and dependence on fossil products.

Swedish road and infrastructure operator Svevia has decided to collaborate with Stora Enso in testing lignin in asphalt. Through this collaboration, Svevia aims to replace part of the oil-based binder with nature’s own binder – lignin, Lineo ™ by Stora Enso. The lignin containing asphalt is currently being tested out on Swedish roads.

October 15, 2020 - Toronto, Ontario - The Government of Canada is building a clean energy future and supporting the natural resource sectors. Forestry is an important source of jobs for Canadians, and the industry continues to find innovative ways to create new markets for Canadian wood.

Elkem has decided to invest in a new biocarbon pilot plant in Canada. The project aims to secure industrial verification of Elkem’s technology for renewable biocarbon, with a long-term goal of contributing to climate-neutral metal production. The technology also has potential for application in other industry sectors, contributing to reduced CO2 emissions.

Wood chips, it must be admitted, are not the most glamorous material around. Scattered in gardens or lining the cages of household pets, it is a commodity that attracts little attention. Luckily, a team of researchers in McGill’s Department of Chemistry developed a method to create carboxylated crystalline nano-cellulose using this often-ignored by-product of the pulp and paper industry.

(UPM, Helsinki, 20.8.2020 at 10:00 EET) FibDex® wound dressing – made from nanofibrillar cellulose by UPM Biomedicals – has taken a significant step in its path to market, as leading medical device distributor Steripolar Oy now sells the product in Finland. FibDex is the first clinical product of renowned forest-based bioindustry company UPM and shows promising signs for future developments, such as cell therapy.

More Articles ...